Market Live : Nifty likely to open higher.

The Nifty50 is likely to open higher on Wednesday following a mixed trend seen in other Asian markets. Overnight, US markets closed higher after the United States temporarily eased curbs on China's Huawei Technologies Co Ltd. Asian stocks were on shaky ground on Wednesday, as earlier relief over Washington's temporary relaxation of curbs against China's Huawei Technologies failed to offset deeper worries about trade frictions between the worlds two largest economies said a Reuters report. Trends on SGX Nifty indicate a positive opening for the broader index in India, a rise of 29.5 points or 0.25 percent. Nifty futures were trading around 11,756-level on the Singaporean Exchange. As many as 140 companies will report their results for March quarter which include names like Ashok Buildcon, Bank of Baroda, Canara Bank, Cipla, Cummins India, IndusInd Bank, MOIL, Thermax, etc. among others.

Global Market:

Asian Markets: Asian markets are higher today as Chinese and Hong Kong shares show gains. The Shanghai Composite is up 0.02% while the Hang Seng is up 0.25%. The Nikkei 225 is not trading.
US Markets: North and South American markets finished mixed as of the most recent closing prices. The Bovespa gained 2.76% and the S&P 500 rose 0.85%. The IPC lost 0.76%.
European Markets: European markets finished higher today with shares in Germany leading the region. The DAX is up 0.85% while France's CAC 40 is up 0.50% and London's FTSE 100 is up 0.25%.

Major Headlines of the day:

Rupee opens at 69.68 per dollar.

DHFL puts fresh deposits, renewals on hold: Media reports The company has been subject to multiple downgrades in recent month.

United Breweries gains 5% post Q4FY19 results The company's total income during the final quarter of FY19 was up 5.84% to Rs3,469.3cr vs. Rs3,277.85cr in the corresponding quarter of the previous fiscal.

BPCL and HPCL fall despite strong Q4 nos; brokerages assign mixed ratings Brokerage firm CLSA has a sell rating on both companies, with a target at Rs 300 per share for BPCL and Rs 210 per share for HPCL. However, Deutsche Bank has a buy rating on both oil refining majors.

Earnings Reaction To Watch
BAJAJ ELECTRIC
BANK OF BARODA
CANARA BANK
CUMMINS
INDUSINDBK
JK LAXMI CEM
RAMCO cement

The trend in FII flows:- The FIIs were Net Value of Rs 1185.44 segment while the DIIs were Net Value of -1090.32 the provisional figures.

Securities in Ban For Trade Date 22-MAY-2019
JETAIRWAYS
RELCAPITAL
ADANIPOWER
IDBI

Get more details here:

  Intraday stock tips, Financial Advisory Company ,Derivative Free Trial,Stock tips
Call on:9977499927
* Investment & Trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.  

Read More

CORPORATE NEWS BY CAPITALSTARS : 20 MAY 2019

Dr. Reddy's declines 7% post Q4FY19 numbers

Shares of Dr. Reddy's declined 7% on Monday in an otherwise strong market despite the company reporting a healthy set of numbers for the quarter, it was in-line on revenue and EBITDA fronts, but ahead on the PAT front.

The company reported revenue growth of 13.4% YoY to Rs4, 029.6cr, broadly in-line with consensus estimates. Due to lower selling and other expenses, EBITDA reported 45.3% YoY growth to Rs818.9cr, in-line with estimates. EBITDA margins stood at 20.3%, 446bps expansion on YoY basis. Led by strong EBITDA growth, company reported PAT of Rs455.4cr, 67.4% YoY growth and ~9% ahead of consensus estimates.

Bharat Forge's Q4FY19 PAT at Rs300cr

Bharat Forge reported Q4FY19 net profit at Rs300cr against Rs100cr in the same quarter last fiscal.

Revenue of the company for Q4FY19 increased by 14% YoY at Rs1,668cr vs. Rs1,467cr in the same period a year ago. Further, EBITDA rose to Rs516cr vs. Rs418cr a year ago.

"FY19 has been a record year for the company with strong revenue and profit growth. In FY19, the company registered a revenue growth of 22.6% and PAT growth of 51.5%. For the quarter, revenues grew by 13.8%, while PAT grew by 198.3% on a YoY basis. We continued to strengthen the balance sheet with all key financial ratios improving compared to FY2018 'SB.N. Kalyani, Chairman & Managing Director of Bharat Forge said.

PSU Bank stocks outperform; Indian Bank, Bank of India stocks surge

The Nifty PSU Bank index was trading 7% up in the morning session on Monday on heavy buying in Indian Bank, Bank of India and Canara Bank.

SBI and Syndicate Bank leads the index's gain by witnessing rally of 8% each. Allahabad Bank and Bank of Baroda also gained 8-9% respectively. PNB, Oriental Bank, Union Bank, J&K Bank, and Central Bank also joined the gainers' group by rising 4-6% respectively.

Jet Airways director Robin Kamark resigns from board

Jet Airways (India) announced that Robin Kamark, nominee director of Etihad Airways PJSC, resigned as director of the Company with effect from May 16, 2019.

The company announced this after-market hour on Friday.

Also, Kuldeep Sharma, Company Secretary and Compliance Officer of the Company, vide his letter dated May 14, 2019, has resigned from the services of the Company with immediate effect, the company said in the filing.

USFDA inspection at Cipla's Indore plant ends with zero observations

Cipla, in its filing to the exchanges, informed that inspection conducted by the United States Food and Drug Administration (USFDA) at the company's Indore facility ended with zero observation.

"USFDA conducted a post-approval inspection at the company's Indore facility from May 13 to May 17, 2019", the company said in a press note after markets hours to the exchanges on Friday.

Get more details here:
Call on:9977499927
* Investment & Trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.  

  Intraday stock tips, Financial Advisory Company ,Derivative Free Trial,Stock tips

Read More

CS OPENING BELL 04-JAN-2018

NIFTY SPOT UP 34 @10706
SENSEX SPOT UP 134 @35648
BANK NIFTY FUTURES UP 64 @27144
HAPPY TRADING!

WWW.CAPITALSTARS.COM+919977499927
CS NIFTY FUTURES (JAN ) OVERVIEW

TREND BEARISH
RES2: 10980
RES 1:10860
SUP1:10550
SUP2:10300

CS BANK NIFTY FUTURES (JAN ) OVERVIEW

TREND BULLISH 
RES 2: 27480
RES 1: 27200
SUP1: 26900
SUP2: 26780

Financial Advisory Company in Indore, Stock Advisory Company in Indore , Equity Tips  , Free Trading Tips  , MCX Tips , sebi registered advisory company , Intraday stock tips , Free commodity tips 

Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance. CapitalStars Investment Adviser: SEBI Registration Number: INA000001647

Read More

CORPORATE NEWS 21-DEC-2018

Government set to pump Rs2,345cr into Air India
The Government has sought Parliamentary approval to infuse Rs2, 300cr into Air India after a failed bid to sell off the airline in May. The Rs2, 300cr is an addition to the Rs27, 000cr already infused into the airline operator over a span of a decade. The cash-strapped airline has been running on taxpayer bailouts and has not made money for more than 10 years.  Air India was set to be sold along with its debt of $5bn. However, the company found no takers so the Centre ambitious plans of privatizing the national airline came to a halt. Hence the Modi government took a decision to turn around the airline.

Sun Pharma secures USFDA approval for Elepsia

Sun Pharma said that its epilepsy drug Epilepsia XR has been approved by the USFDA. This is a New Drug Approval. EPILEPSIA is a novel formulation of Levetiracetam 1000mg and 1500mg and is indicated for adjunctive therapy in the treatment of partial onset seizures in patients 12 years of age. The drug is developed by Sun Pharma Advanced Research Company (SPARC). Sun Pharma has in-licensed this drug from SPARC in July 2016. Epilepsia XR had secured a USFDA approval in March 2015, however, due to compliance issues at Halol, Sun Pharma received a complete response letter (CRL) in September 2015. With the Halol clearance received in June 2018, this drug was expected to get a USFDA approval soon.

Aurobindo Pharma gets USFDA approval for Potassium Chloride ER tablets

Aurobindo Pharma has received final approval from the US Food & Drug Administration (USFDA) to manufacture and market Potassium Chloride extended-release tablets, 8 mEq (600 mg) and 10 mEq (750 mg).
Potassium Chloride Extended-Release tablets, a generic version of Upsher-Smith  Klor-Con Extended-Release tablets, will be launched in January 2019. The approved product has an estimated market size of ~$60mn for the twelve months ending October 2018, according to CQ VIA.

Indiabulls Real Estate sells a stake in 2 projects in Gurugram

Indiabulls Real Estate shares were up 1% in early morning trade on Friday as the company announced in a BSE press release that it has signed a deal with subsidiaries owned by The Blackstone Group L.P., a globally renowned real estate private equity investor. The deal was signed so that IndiaBulls Real Estate could divest up to 50% stake in two office assets in Udyog Vihar, Gurugram, aggregating 784,000 sq.ft. Leasable office space.

Bosch announces the suspension of manufacturing operations at Bidadi plant for two days

Leading technology and auto ancillary company, Bosch Limited (Bosch), part of the Robert Bosch Group, announced that it was suspending manufacturing operations at its Bidadi (Karnataka) plant for two days i.e. December 28 and 29, 2018. The move is aimed at adjusting production with market demand. The company mentioned in its release to stock exchanges that the suspension was due to the fact that volumes at the plant had reduced due to a reduction in customers requirement. It also mentioned that there was no financial impact on account of the proposed suspension of operations. Bosch has a total of 8 manufacturing plants in India.

Financial Advisory Company in Indore, Stock Advisory Company in Indore , Equity Tips  , Free Trading Tips  , MCX Tips , sebi registered advisory company , Intraday stock tips , Free commodity tips 

Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance. CapitalStars Investment Adviser: SEBI Registration Number: INA000001647

Read More

CS OPENING BELL 18-DEC-2018

NIFTY SPOT DOWN 52 @10836

SENSEX SPOT DOWN 168 @36102

BANK NIFTY FUTURES DOWN 124  @26970

HAPPY TRADING!

WWW.CAPITALSTARS.COM+919977499927

CS NIFTY FUTURES (DEC ) OVERVIEW

TREND BEARISH

RES2: 10980

RES 1:10880

SUP1:10600

SUP2:10430 

CS BANK NIFTY FUTURES (DEC ) OVERVIEW

TREND BULLISH

RES 2: 27350

RES 1: 27100

SUP1: 26620

SUP2: 26480 

Financial Advisory Company in Indore, Stock Advisory Company in Indore , Equity Tips  , Free Trading Tips  , MCX Tips , sebi registered advisory company , Intraday stock tips , Free commodity tips 

Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance. CapitalStars Investment Adviser: SEBI Registration Number: INA000001647

Read More

Nifty likely to open lower 06-DEC-2018

Indian Indices:                           Trends on SGX Nifty indicate that the index will open 87.50 points or 0.81 per cent lower in India.

Global Market:

·       Asian markets: Asian markets are lower today as Japanese and Hong Kong shares fall. The Nikkei 225 is off 1.84% while the Hang Seng is down 2.78%. The Shanghai Composite is not trading.

·       US Markets: Market sell-off set to continue as Dow futures get hit.

·       European markets: European markets finished sharply lower today with shares in London leading the region. The FTSE 100 is down 1.44% while France's CAC 40 is off 1.36% and Germany's DAX is lower by 1.19%.

·       Major Headlines of the day:

·       OPEC, Russia move closer to cutting oil output.

·       OPEC meets on Thursday in Vienna, followed by talks with allies such as Russia on Friday. OPEC's de facto leader, Saudi Arabia, has indicated a need for steep output reductions from January, fearing a glut, but Russia has resisted a large cut.

·         Trend in FII flows:-  The FIIs were Net Value of Rs  -357.82 segment while the DIIs were Net Value of  -791.59 the provisional figures.

Securities in Ban For Trade Date 06-DECEMBER-2018

NIL

 Financial Advisory Company in Indore, Stock Advisory Company in Indore , Equity Tips  , Free Trading Tips  , MCX Tips , sebi registered advisory company , Intraday stock tips , Free commodity tips 

Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance. CapitalStars Investment Adviser: SEBI Registration Number: INA000001647

Read More

CS OPENING BELL 03-DEC-2018

NIFTY SPOT UP 40 @10917

SENSEX SPOT UP 171 @36365

BANK NIFTY FUTURES UP 100 @ 29963

HAPPY TRADING!

WWW.CAPITALSTARS.COM  +919977499927

CS NIFTY FUTURES (DEC ) OVERVIEW

TREND BULLISH

RES2: 11100

RES 1:11000

SUP1:10850

SUP2:10750 

CS BANK NIFTY FUTURES (DEC ) OVERVIEW

TREND BULLISH

RES 2: 27300

RES 1: 27000

SUP1: 26700

SUP2: 26500 

Financial Advisory Company in Indore, Stock Advisory Company in Indore , Equity Tips  , Free Trading Tips  , MCX Tips , sebi registered advisory company , Intraday stock tips , Free commodity tips 

Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance. CapitalStars Investment Adviser: SEBI Registration Number: INA000001647

Read More

CS OPENING BELL 29-Nov-2018

NIFTY SPOT UP 62 @10789

SENSEX SPOT UP 250 @35962

BANK NIFTY FUTURES UP 140 @26631

HAPPY TRADING!

WWW.CAPITALSTARS.COM+919977499927

CS NIFTY FUTURES (NOV ) OVERVIEW

TREND BEARISH

RES2: 10900

RES 1:10840

SUP1:10700

SUP2:10560 

CS BANK NIFTY FUTURES (NOV ) OVERVIEW

TREND BULLISH

RES 2: 26790

RES 1: 26680

SUP1: 26300

SUP2: 25900 

Financial Advisory Company in Indore, Stock Advisory Company in Indore , Equity Tips  , Free Trading Tips  , MCX Tips , sebi registered advisory company , Intraday stock tips , Free commodity tips 

Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance. CapitalStars Investment Adviser: SEBI Registration Number: INA000001647

Read More